Breast Cancer 2021 | Webinar | | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

One team, One dream, Let's find a cure

- Breast Cancer 2021

Welcome Message

We cordially invite you to the 9th European Congress on Breast Cancer, Women's Health, and Therapeutics with great pleasure we invite attendees to this world conference of researchers, doctors, gynecologists, and other healthcare specialists.

The theme of the conference is One team, One dream, Let’s find a cure.

Breast Cancer 2021 offers a venue for networking with renowned professionals from other nations and presents a chance to advance one's career. The conference schedule includes plenary sessions, poster presentations, special sessions, keynote addresses, and much more. The purpose of this conference is to bring together all of the research scholars, academic researchers, medical professionals, clinical healthcare specialists, and young researchers in order to raise the bar for academic excellence.

The scientific conference cover topics such as male Breast Cancer, Gynecology and obstetrics, new clinical trials, and Breast Cancer surgery. This conference acts as a fantastic forum for discussion and gives researchers insight into innovation, development, cures, and progression.

We sincerely welcome everyone to Breast Cancer 2021 and are delighted to offer a venue in The with the goal is to impacting science. We are hoping that you will all attend our conference and work with us to improve women's health.

Scientific Sessions/Tracks

Session 1: Breast Cancer

Healthcare professionals worldwide are working to develop better strategies for addressing, preventing, diagnosing, and treating Breast Cancer as well as enhancing patient satisfaction with their care. General information regarding Breast Cancer and its risk factors is covered in this Breast Cancer conference. The session includes general information about Breast cancer 2023 and the risk factors associated with it. The discussion here contains the various types of research going on about the intensity of Breast cancer, the risk factors, the impact of it on Women health, and necessary precautions and treatment to be taken before the worse.

Associated Journals: Journal of Cancer immunology, Journal of clinical oncology, Journal of medical cancer research, International journals of radiation oncology, Journal of cancer immunotherapy, European Journal of Breast Cancer, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Associated Societies: American Breast Cancer Societies, Breast Cancer Research Foundation, Breast Cancer Steering Committee, European society of Breast cancer, International Gynecologic cancer society, society of surgical oncology, American societies of a Breast Surgeon, Advisory Committee on Breast Cancer in young women, British Oncology Society

Session2: Screening of Breast Cancer

Screening tests for Breast Cancer 2023 are to identify cancers before they start to have any negative effects. Early identification refers to the use of a method or test that enables the analysis of breast development earlier than would typically be possible to stop the Breast disease in its early phases, you must learn about screening tests and diagnostic tools for the disease. There are several ways to check for Breast cancer A few tests are essential, while others are more intrusive but provide more information. It is essential to recognize this bosom growth illness early on, regardless One of the most well-known screening methods for Breast Cancer is mammography.

Associated Journals: International journal of Breast screening, Journal of Cancer immunology, Journal of medical cancer research, International journals of radiation oncology, Journal of cancer immunotherapy, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of clinical oncology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Associated Societies: Breast imaging society, American Breast Cancer Societies, Breast Cancer Steering Committee, European Society of Breast Imaging, International Gynecologic cancer society, society of surgical oncology, American societies of a Breast Surgeon, Advisory Committee on Breast Cancer in young women, British Oncology Society

Session 3: Surgery for Breast Cancer

The common way to remove a Tumor in cancer has always been by surgery. It is the most widely used cancer therapy strategy. Sometimes testing is delayed until after breast-conserving surgery (BCS) or a mastectomy, which removes the entire malignancy. Breast Cancer 2023 surgery methods include segmental mastectomy (Breast-conserving surgery), lumpectomy, partial mastectomy, and double mastectomy (Complete Breast removal) The type of surgery is selected depending on how fast the cancer is growing. Breast-conserving surgery removes cancer while conserving the breast, whereas mastectomy removes the complete breast while preventing cancer from spreading to other organs. It is also a common procedure to operate to remove adjacent lymph nodes.

Associated Journals: Journal of Cancer immunology, Journal of Women Health Care, Journal of Psychiatry, Journal of clinical oncology, Journal of Breast Cancer metastasis, International Journal of Women Health, Journal of medical cancer research, International journals of radiation oncology, Journal of cancer immunotherapy, European Journal of Breast Cancer, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Associated Societies: American Breast Cancer Societies, Society of Women Health Research, Breast Cancer Research Foundation, Breast Cancer Steering Committee, National Women Network, European society of breast cancer, International Gynecologic cancer society, society of surgical oncology, American societies of Breast Surgeon, British Oncology Society

Session 4: Breast Reconstruction

Breast reconstruction is the procedure of reshaping the Breast, typically in Breast Cancer survivors. The mastectomy fully removes the Women's Breasts from them. The women's lifestyle and mental health may be impacted. The significance of Breast surgery 2023 and the patients' post-treatment lives are discussed in this session.

Associated Journals: Journal of Cancer immunology, Journal of clinical oncology, Journal of medical cancer research, International journals of Radiation oncology, Journal of cancer immunotherapy, European Journal of Breast Cancer, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Associated Societies: American Breast Cancer Societies, Breast Cancer Research Foundation, Breast Cancer Steering Committee, European society of breast cancer, International Gynecologic cancer society, society of surgical oncology, American societies of a Breast Surgeon, Advisory Committee on Breast Cancer in young women, British Oncology Society

Session 5: Breast disease

The majority of Breast lumps are Benign, or non-cancerous Fibrocystic breasts that are Benign (noncancerous) can appear in both men and women. The term "Benign Breast Disease" refers to this ailment. While neither malignant nor life-threatening, these breast alterations may raise your chance of Breast Cancer in the future.

Associated Journals: International journal of Breast screening, Journal of Cancer immunology, Journal of medical cancer research, International journals of Radiation oncology, Journal of cancer immunotherapy, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of clinical oncology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Session 6: Breast Cancer Resuscitation

Recovery from cancer therapy may sound like a survival struggle. The reality is that there will be new decisions to be made and perhaps even new chances in life after treatment, particularly for women with Breast Cancer. There are several things that should be applied in daily life to prevent the recurrence of Breast Cancer, such as changing one's eating habits and engaging in regular exercise. the level of estrogen may also decrease, which causes bone density to decline. Exercise can help to increase bone thickness and can be used to stop breast development cycles.

Session 7: Male Breast Cancer

Similar to Breast Cancer 2023 in women, a male chest condition refers to unchecked growth with the potential or spread of some of the cells in this chest tissue. They eventually become so distinctive and direct that they are referred to as cancer cells. Both young men and young women have channels, which are tubular structures, in their chest tissue. Breast cancer can occur in men, despite the fact that women are more likely to have it. Men also have a limited amount of non-functioning Breast tissues in the chest area. According to data from the American Cancer Society, 480 men die from Breast Cancer on average each year. About 2550 males are impacted by the disease.

Session 8: Treatment for Breast Cancer

The two types of treatment for Breast cancer 2023 are local and systemic, and an individual's level of health and well-being relies on their underlying medical condition. Various therapy approaches are used depending on the situation Surgery is the cornerstone of treating bosom disease when the cancer is contained, followed by chemotherapy for cancers that are ER-positive, adjuvant hormonal therapy (with tamoxifen or an aromatase inhibitor). A multidisciplinary team attempts to manage Breast cancer in accordance with national and international regulations, each risk category adhering to different treatment standards. Radiation therapy, chemotherapy, hormone therapy, and invulnerable treatments are all available therapeutic results.

About Conference

Our conference's topic includes a wide range of major sessions that provide a deep understanding of breast cancer. Breast Cancer can have an impact on a woman's overall well-being, including immune system problems, cell degeneration, different stages of malignancy, and even the loss of all health and well-being. The conference's main highlights are the pioneers in the field of research and their research projects.

Prominent members of the scientific community who have made significant contributions to the fields of cancer and Breast cancer are participating in the event.

Aim of the conference

To gather in one location for the advancement of science, researchers, scientist, physicians, young academics, and other healthcare professionals.
To talk about the newest developments and trends in Breast Cancer research.
to investigate the possibilities and consider the difficulties in the advancement of medicines for women.
To investigate and discuss novel concepts by creating a forum for speakers and attendees to communicate.
To identify strategies for advancing Breast Cancer, women health, and therapies research in the near future.

We would like to express our gratitude to all of our fantastic keynote speakers, presenters, conference participants, students, associations, media partners, exhibitors, and guests for helping to make Breast Cancer 2021 a wonderful and successful event.

Past Conference report:

Allied Academies held the event of the 8th European Congress on Breast cancer, Women’s health, and therapeutics as Webinar on April 27-29,2023 with the topic "Novel trends and advancements in the research of Breast cancer and Women’s health"

This Conference is one of the most interesting and successful events from Allied Academies in 2021 because to the active involvement and generous replies from organizing committee members, scientists, young and sensible researchers, corporate delegations, and academic communities.

The conference was highlighted by the presence of young and brilliant academics, business representatives, and talented student communities from more than 18 nations, who have propelled this event to success. Several talks on the most recent retroviral research served as conference highlights.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Breast cancer

Types of Breast cancer

Surgery for breast cancer

Breast cancer treatment

Breast cancer rehabilitation

Allied Academies has recognized the organizing committee, keynote speakers, and other contributors who made this event a success and appreciates the time and effort put forward by all of the presenters and wishes them luck in their future endeavors.

Market Analysis

The global diagnostics of breast cancer 2023 market was worth USD 3.9 billion in 2020 and is predicted to increase at a compound annual growth rate (CAGR) of 7.0% between 2021 and 2028. The increased prevalence of cancer and rising government measures to influence screening and diagnosis rates can be related to the increase. The market for women’s health diagnostics is anticipated to be driven by the rising incidence of Breast cancer. According to the American Cancer Society, 281,550 new instances of breast cancer will be discovered in 2021, and 49,290 Americans will pass away from the disease. The WHO, Breast cancer will be the most frequent type of cancer in the world in 2021, with more than 2.3 million new cases.

Growing demand for technologically advanced devices that may improve accuracy, speed, and cost-effectiveness is expected to be the most important growth factor over the projection period. In the field of cancer diagnostics, for example, Direct-To-Consumer (DTC) testing has been introduced. The U.S. FDA approved 23andMe's first DTC BRCA test, which was released in 2018. It is one of the earliest direct-to-consumer tests (DTC) for BRCA gene abnormalities, which raise the risk of breast and ovarian cancer. The instrument-based testing segment lead the Breast cancer diagnostics market in 2020, accounting for 72.7% of total revenue

Europe Breast Cancer Therapeutics 2023 Market reached USD 8.2 billion and is expected to grow at a 7.1% CAGR between 2024 and 2028. Breast cancer therapeutics belongs to the therapeutic approach used in the treatment or management of local recurrence and metastatic Breast cancer spread. Breast cancer 2023 therapeutics in the form of immunotherapy, hormonal therapy, chemotherapy, targeted therapy, or a combination of these therapies are increasingly preferred in cases of metastatic relapse risk. The presence of major players, well-established diagnostic and screening infrastructure, technological advancements, high patient awareness, and healthcare expenditure are the major factors contributing to this region's dominance.

According to the World Health Organization, screening with mammography clearly reduces breast cancer 2023 mortality. In women aged 50 and up, an optimal cancer screening program with adequate compliance could reduce Breast cancer mortality by at least 20%. Because of improved clinical outcomes, the majority of European Union member states have or are planning to launch a population-based screening campaign for Breast cancer mammography. In 2021, the targeted therapy segment accounted for roughly 70% of the European Breast cancer therapeutics market. Targeted therapy, which improves the precision of antitumor function while reducing toxicity and damage to normal tissues, is an important component of Breast cancer treatment. Technological advancements and increased research activities in targeted therapy are expected to drive segment growth further. Two Phase III clinical trials are currently underway to compare the efficacy of PARP inhibitors to standard chemotherapy.

The Netherlands Cancer Registry has cancer registry data for the entire country dating back to 1989. (NCR). 5 Long-term trends in cancer epidemiology can be easily studied in the Netherlands due to the high-quality long-running cancer registry. Previously, these data were used to calculate lifetime risks. However, the most frequently cited estimate is from 2003. At the time, the average lifetime risk for invasive tumors was estimated to be 1 in 8 (12.7%),6 while the estimate including in situ tumors was nearly 1% higher.

The risks are determined by the number of diagnoses or deaths in this cohort. All-cause mortality is taken into account when adjusting risks for competing causes of death. The National Cancer Institute developed the DevCan software, which incorporates this method. 10 The program provides risks and 95% confidence intervals (CI) for each 5-year age group. 11,12 The female mid-year population was used to calculate the risk population. This was calculated as the female population's average on January 1 and December 31 of the same year.

In the Netherlands, over 13 000 women were diagnosed with invasive breast cancer in 2010. In 2010, the lifetime risk of developing invasive breast cancer 2023 was estimated to be 13.6% (1 in 7.4 women). The absolute risk difference between 1990 and 2000 is 3.1% (10.5%, or one in every 9.5 women) and 1.1% (12.5%, or one in every 8.0 women), respectively. When DCIS tumors are included, the lifetime risk for 2010 rises by 1.7%. As a result, the combined risk of breast cancer is 15.2%. (1 in 6.6 women). In 1990, the combined risk was 10.8% (1 in 9.3 women) and in 2000, it was 13.5% (1 in 7.4 women).

Organizing committee members

Dr. Alireza Heidari, Ph.D., D.Sc

Full Professor & president, Oncology and Cancer Research

American International Standards Institute (AISI), USA

Dr Riyad Bendardaf

Clinical Associate Professor, Oncology

College of Medicine, University of Sharjah, UAE

ALFRED PATRICK MINA, MD

Associate Professor, Health care

1 Beijing Municipal Key Laboratory of Child Development and Nutriomics, American Samoa

Zhennan Liu, phd

Associate Professor, Health care

Denmark

Renowned Speakers

Cristian Arriaga Canon, MBBS

Student, Health care

"University College London ", england, United Kingdom

Diana Elisa Zamora Avila, MD

Associate Professor, Health care

France

Russellee Caringal, phd

Associate Professor, Health care

France

Zhennan Liu, phd

Associate Professor, Health care

"Unviersite du Quebec a Chicoutimi, Central America

Tarek Mohamed Kamal Mohamed Metawi, phd

Associate Professor, Health care

Dubai

To Collaborate Scientific Professionals around the World

Conference Date	October 20-21, 2021
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Joana Martins Pisco

Rua Custódio Vieira,

What a great event! Had a chance to connect with other strong business women in today’s housing industry. The energy was through the roof. I am ready to make 2015 my best year yet due to the best practices I learned while at the conference e

Georg Verch

Germany

Attendees will make invaluable business connections and friends for life. This conference will teach people how to navigate through the federal government system.

Zhennan Liu

researcher

It was definitely a groundbreaking conference. It was unquestionably out of the norm; very innovative and unique sessions. Having the SBA there was truly beneficial. I thought it was a great event to help grow my business.

ALFRED PATRICK MINA

proffessor